Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study

References

• Miller KD, Ortiz AP, Pinheiro PS, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021;71(6):466–487. doi:10.3322/caac.21695
   PubMed Web of Science ®Google Scholar
• Wu J, Lin Z. Non-Small Cell Lung Cancer Targeted Therapy: drugs and Mechanisms of Drug Resistance. Int J Mol Sci. 2022;23(23):15056. doi:10.3390/ijms232315056
   PubMed Web of Science ®Google Scholar
• Błach J, Wojas-Krawczyk K, Nicoś M, et al. Failure of immunotherapy-the molecular and immunological origin of immunotherapy resistance in lung cancer. Int J Mol Sci. 2021;22(16):9030. doi:10.3390/ijms22169030
   PubMed Web of Science ®Google Scholar
• Zhang CL, Zhu KP, Ma XL. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 2017;396:66–75. doi:10.1016/j.canlet.2017.03.018
   PubMed Web of Science ®Google Scholar
• Theodoulou FL, Kerr ID. ABC transporter research: going strong 40 years on. Biochem Soc Trans. 2015;43(5):1033–1040. doi:10.1042/BST20150139
   PubMed Web of Science ®Google Scholar
• Paolini A, Baldassarre A, Del Gaudio I, et al. Structural Features of the ATP-Binding Cassette (ABC) Transporter ABCA3. Int J Mol Sci. 2015;16(8):19631–19644. doi:10.3390/ijms160819631
   PubMed Web of Science ®Google Scholar
• Hellsberg E, Montanari F, Ecker GF. The ABC of Phytohormone Translocation. Planta Med. 2015;81(6):474–487. doi:10.1055/s-0035-1545880
   PubMed Web of Science ®Google Scholar
• Meschini S, Marra M, Calcabrini A, et al. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol In Vitro. 2002;16(4):389–398. doi:10.1016/s0887-2333(02)00035-8
   PubMed Web of Science ®Google Scholar
• Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, et al. Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy. Int J Mol Sci. 2021;22(16):8885. doi:10.3390/ijms22168885
   PubMed Web of Science ®Google Scholar
• Fan W, Shao K, Luo M. Structural View of Cryo-Electron Microscopy-Determined ATP-Binding Cassette Transporters in Human Multidrug Resistance. Biomolecules. 2024;14(2):231. doi:10.3390/biom14020231
   PubMed Web of Science ®Google Scholar
• Ou Z, Zhang Y, Wang Y. Research Progress on Pharmacological Mechanism of Curculigoside[J]. Guangdong Chemical Industry. 2023;50(05):117–119. Chinese
   Google Scholar
• Chen J, Guo X, Liu X. Research progress on chemical constituents,pharmacological and toxicology effects of Curculigo orchioides Gaertn[J]. Journal of Traditional Chinese Chinese Medicine. 2021;36(07):4151–4158. Chinese
   Google Scholar
• Hao Y, Zhu B, Xue C. Sensitivity-enhancing Mechanism of Curculiginis Rhizoma in Cisplatin-resistant Non-small Cell Lung Cancer Cells Based on P-glycoprotein[J]. World Chinese Medicine. 2022;17(24):3462–3466+3471. Chinese
   Google Scholar
• Weinstein JN, Collisson EA, Mills GB, et al.; Cancer Genome Atlas Research Network. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113–1120. doi:10.1038/ng.2764
   PubMed Web of Science ®Google Scholar
• Fang L, Wang H, Li P. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer. Invest New Drugs. 2018;36(2):187–194. doi:10.1007/s10637-017-0523-3
   PubMed Web of Science ®Google Scholar
• Byers LA, Diao L, Wang J, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19(1):279–290. doi:10.1158/1078-0432.CCR-12-1558
   PubMed Web of Science ®Google Scholar
• Dalvi MP, Wang L, Zhong R, et al. Taxane-platin-resistant lung cancers co-develop hypersensitivity to jumonjic demethylase inhibitors. Cell Rep. 2017;19(8):1669–1684. doi:10.1016/j.celrep.2017.04.077
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883. doi:10.1093/bioinformatics/bts034
   PubMed Web of Science ®Google Scholar
• Kassambara A, Kassambara MA. Package ‘ggpubr’. R Package Version 0.1. 2020;6.
   Google Scholar
• Kassambara A. Package ‘survminer’. Drawing Survival Curves Using ‘ggplot2’(R Package Version. 2017.
   Google Scholar
• Dai YH, Wang YF, Shen PC, et al. Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. NPJ Genom Med. 2021;6(1):40. doi:10.1038/s41525-021-00200-0
   PubMed Web of Science ®Google Scholar
• Therneau TM, Lumley T. Package ‘survival’. R Top Doc. 2015;128(10):28–33.
   Google Scholar
• Fennell DA, Summers Y, Cadranel J, et al. Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat Rev. 2016;44:42–50. doi:10.1016/j.ctrv.2016.01.003
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869–1883. doi:10.1038/onc.2011.384
   PubMed Web of Science ®Google Scholar
• Singh AP, Adrianzen Herrera D, Zhang Y, et al. Mouse models in squamous cell lung cancer: impact for drug discovery. Expert Opin Drug Discov. 2018;13(4):347–358. doi:10.1080/17460441.2018.1437137
   PubMed Web of Science ®Google Scholar
• Lim ZF, Ma PC. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. J Hematol Oncol. 2019;12(1):134. doi:10.1186/s13045-019-0818-2
   PubMed Web of Science ®Google Scholar
• Yi Q, Feng J, Liao Y, et al. Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application. IUBMB Life. 2023;75(3):225–237. doi:10.1002/iub.2624
   PubMed Web of Science ®Google Scholar
• Yan H, Tang S, Tang S, et al. miRNAs in anti-cancer drug resistance of non-small cell lung cancer: recent advances and future potential. Front Pharmacol. 2022;13:949566. doi:10.3389/fphar.2022.949566
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Qin Z, et al. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol. 2021;17(3):291–306. doi:10.1080/17425255.2021.1887139
   PubMed Web of Science ®Google Scholar
• Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156–1166. doi:10.1101/gr.184901
   PubMed Web of Science ®Google Scholar
• Yang H, Yao J, Yin J, et al. Decreased LRIG1 in Human Ovarian Cancer Cell SKOV3 Upregulates MRP-1 and Contributes to the Chemoresistance of VP16. Cancer Biother Radiopharm. 2016;31(4):125–132. doi:10.1089/cbr.2015.1970
   PubMed Web of Science ®Google Scholar
• Liu X. Study on the Expression and Clinical Meaning of LRP Genes in Non-Small Cell Lung Cancer. Dalian Medical University; 2012. In Chinese.
   Google Scholar
• Taheri M, Motalebzadeh J, Mahjoubi F. Expression of LRP Gene in Breast Cancer Patients Correlated with MRP1 as Two Independent Predictive Biomarkers in Breast Cancer. Asian Pac J Cancer Prev. 2018;19(11):3111–3115. doi:10.31557/APJCP.2018.19.11.3111
   PubMedGoogle Scholar
• Zhang L, Li Y, Wang Q, et al. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer. Mol Cancer. 2020;19(1):10. doi:10.1186/s12943-019-1112-1
   PubMed Web of Science ®Google Scholar
• Lin H, Hu B, He X, et al. Overcoming Taxol-resistance in A549 cells: a comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. Biochem Pharmacol. 2020;171:113733. doi:10.1016/j.bcp.2019
   PubMed Web of Science ®Google Scholar
• Adorni MP, Galetti M, La Monica S, et al. A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC. Int J Mol Sci. 2023;24(2):989. doi:10.3390/ijms24020989
   PubMed Web of Science ®Google Scholar
• Xiaoqing W, Chang L, Wenping L. Effects of Yiqi Huoxue Jiedu Fang on macrophage phenotype in patients with platinum-resistant ovarian cancer through regulating IL-6. Journal of Beijing University of Traditional Chinese Medicine. 2022;45(02):208–216. In Chinese.
   Google Scholar
• Shen F, Jiayue X, Han F. Mechanism of Chinese Herbal Monomers Against Cisplatin-induced Resistance of Ovarian Cancer: A Review. Chinese Journal of Experimental Traditional Medical Formulae. 2022;28(03):226–233. In Chinese.
   Google Scholar
• Zhang W, Mao X. Research progress on molecular compatibility in integrated Chinese and Western medicine to foster synergy and reverse resistance of cancer cells to anticancer drugs[J]. Chinese Journal of Clinical Oncology. 2021;48(11):566–570. Chinese
   Google Scholar
• Zhu F, Zhang Y. Analysis of the effect of curculigoside on proliferation and differentiation of osteoblasts and the expression of inflammatory cytokines and its mechanism. Chinese Journal of Osteoporosis. 2019;25(5):642–648. In Chinese.
   Google Scholar
• Cai K, Wang X. Effects of Curculigo orchioides polysaccharide on the immunity of immunocompromised mice induced by cyclophosphamide. China J Trad Chin Med Pharm. 2016;31(12):5030–5034. In Chinese.
   Google Scholar
• Jouan E, Le Vée M, Mayati A, et al. Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay. Pharmaceutics. 2016;8(2):12. doi:10.3390/pharmaceutics8020012
   PubMed Web of Science ®Google Scholar
• Sehgal V, Ram PT. Network Motifs in JNK Signaling. Genes Cancer. 2013;4(9–10):409–413. doi:10.1177/1947601913507577
   PubMedGoogle Scholar
• Xu L, Fu Y, Li Y, et al. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. Cancer Chemother Pharmacol. 2017;80(2):235–242. doi:10.1007/s00280-017-3355-0
   PubMed Web of Science ®Google Scholar
• Tajitsu Y, Ikeda R, Nishizawa Y, et al. Molecular basis for the expression of major vault protein induced by hyperosmotic stress in SW620 human colon cancer cells. Int J Mol Med. 2013;32(3):703–708. doi:10.3892/ijmm.2013.1428
   PubMed Web of Science ®Google Scholar
• Skrypek N, Vasseur R, Vincent A, et al. The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. Oncotarget. 2015;6(13):10853–10867. doi:10.18632/oncotarget.3414
   PubMedGoogle Scholar
• Zhang Y, Zhou J, Xu W, et al. JWA sensitizes P-glycoprotein-mediated drug-resistant choriocarcinoma cells to etoposide via JNK and mitochondrial-associated signal pathway. J Toxic Environ Health A. 2009;72(11–12):774–781. doi:10.1080/15287390902841649
   PubMed Web of Science ®Google Scholar